Abstract
Anaphylactic shock is a sudden and often fatal syndrome that can occur when antigen combines with antibodies in a sensitized individual. The reaction involves at least two steps, i.e. fixation of bivalent immunoglobulin and activation of processes leading to release of vasoactive mediators from the cell. The effects of this acute allergic reaction include hypotension, hypovolemia, bronchoconstriction, increased capillary permeability, and stasis and hemorrhage in visceral vascular beds. The actions of various mediators, and thus the prominence of these manifestations of shock, vary from one animal species to another. For example, in dogs, the more pronounced effects of anaphylactic shock are hypotension, portal venous constriction, and hemorrhage of the gastrointestinal tract. In guinea pigs, bronchoconstriction is most prominent, and anaphylaxis in man may be manifest by a combination of urticaria, hypotension, and bronchoconstriction.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Åborg, C.H., J. Novotny, and V. Uvnäs. Ionic binding of histamine in mast cell granules. Acta physiol. scand. 69: 276–283, 1967.
Adams-Ray, J., A. Dahlstrom, and C. Sachs. Uptake of 3,4-dihydroxyphenylalanine and 5-hydroxytryptophan by catechola- mine-forming mast cells in the hamster. Acta physiol. scand. 67: 295–299, 1966.
Änggärd, E., B. Bergqvist, B. Högberg, K. Johansson, I.L. Thon, and B. Uvnäs. Biologically active principles occurring in histamine release from cat paw, guinea pig lung, and isolated rat mast cells. Acta physiol. scand. 59: 97–110, 1963.
Archer, G.T. Release of heparin from the mast cells of the rat. Nature (London) 191: 90, 1961.
Archer, G.T., and M. Jackas. Disruption of mast cells by a component of eosinophil granules. Nature (London) 205: 599–600, 1965.
Assem, E.S.K., and H.O. Schild. Inhibition by sympathomimetic amines of histamine release by antigen in passively sensitized human lung. Nature (London) 224: 1028–1029, 1969.
Austen, K.F., and Bloch, K.J. Differentiation in vitro of antigen-induced histamine release from complement-dependent immune injury. In Boston: Ciba Foundation Symposium on Complement, edited by G.W. Wolstenholme and J. Knight. Little, Brown & Co., 1965.
Becker, E.L., and K.F. Austen. A comparison of the specificity of inhibition by phosphonate esters of the first component of complement and the antigen-induced release of histamine from guinea pig lufig. J. Exptl. Med. 120: 491–506, 1964.
Becker, E.L., and Austen, K.F. Mechanisms of immunologic injury of rat peritoneal mast cells. I. The effect of phosphonate inhibitors on the homocytotropic antibody-mediated histamine release and the first component of rat complement. J. Exptl. Med. 124: 379–395, 1966.
Benditt, E.P., R.L. Wong, M. Arase, and E. Roeper. 5-Hydroxytryptamine in mast cells. Proc. Soc. Exptl. Biol. Med. 90: 303–304, 1955.
Benditt, E.P., and M. Arase. An enzyme in mast cells with properties like chymotrypsin. J. Exptl. Med. 110: 451–460, 1959.
Bloom, G.D., and N. Chakravarty. Time course of anaphylactic histamine release and morphological changes in rat peritoneal mast cells. Acta physiol. scand. 78: 410–419, 1970.
Chakravarty, N. The mechanism of histamine release in anaphylactic reaction in guinea pig and rat. Acta physiol. scand. 48: 146–166, 1960.
Cochrane, C.G., and H.J. Muller-Eberdard. The derivation of two distinct anaphylatoxin activities from the third and fifth components of human complement. J. Exptl. Med. 127: 371–385, 1968.
Dale, H.H., and P.P. Laidlaw. Histamine shock. J. Physiol. 52: 355–390, 1918–19.
Diamant, B., and P.G. Kruger. Histamine release from isolated rat- peritoneal mast cells induced by adenosine 5-triphosphate. Acta physiol. scand. 71: 291–302, 1967.
Diamant, B., and P.G. Kruger. Structural changes of isolated rat peritoneal mast cells induced by adenosine triphosphate and adenosine diphosphate. J. Histochem. Cytochem. 16: 707–716, 1968.
Dias da Silva, W., and I.H. Lepow. Complement as a mediator of inflammation. II. Biological properties of anaphylatoxin prepared with purified components of human complement. J. Exptl. Med. 125: 921–946, 1967.
Douglas, W.W. Stimulus secretion coupling: The concept and clues from chromaffin and other cells. Brit. J. Pharmacol. 34: 451–474, 1968.
Falk, B., T. Nystedt, E. Rosengren, and J. Stenflo. Dopamine and mast cells in ruminants. Acta pharmacol. toxicol. 21: 51–58, 1964.
Fawcett, D.W. Physiologically significant specializations of the cell surface. Circulation 26: 1105–1126, 1962.
Garcia-Arocha, H. Release of histamine and 5-hydroxytryptamine from cells of the peritoneal fluid of rats. Can. J. Biochem. Physiol. 39: 395–403, 1961.
Garcia-Arocha, H. Liberation of 5-hydroxytryptamine and histamine in the anaphylactic reaction of the rat. Can. J. Biochem. Physiol. 39: 403–416, 1961.
Giacobini, E., G. Sedvall, and B. Uvnls. Phosphatidase A activity of isolated rat mast cells and of red blood cells, white blood cells, and spinal ganglion cells. Exptl. Cell Res. 37: 368–375, 1965.
Gillespie, E., R.J. Levine, and S.E. Malawista. Histamine release from rat peritoneal mast cells: Inhibition by colchicine and potentiation by deuterium oxide. J. Pharmacol. Exptl. Therap. 164: 158–165, 1968.
Goth, A. Effect of drugs on mast cells. Advan. Pharmacol. 5: 47–78, 1967.
Hogberg, B., and B. Uvnäs. Further observations on the disruption of rat mesentery mast cells caused by compound 48/80, antigen-antibody reaction, lecithinase A, and decylamine. Acta physiol. scand. 48: 133–145, 1960.
Ishizaka, K. Human reaginic antibodies. Ann. Rev. Med. 21: 187–200, 1970.
Ishizaka, T., K. Ishizaka, R.P. Orange, and K.F. Austen. The capacity of human immunoglobulin E to mediate the release of histamine and slow-reacting substance of anaphylaxis from monkey lung. J. Immunol. 104: 335–343, 1970.
Ishizaka, T., K. Ishizaka, R.P. Orange, and K.F. Austen. Pharmacologic inhibition of the antigen-induced release of histamine and slow-reacting substance of anaphylaxis (SRS-A) from monkey lung tissues mediated by human IgE. J. Immunol. 106: 1267–1273, 1971.
Janoff, A., S. Schaefer, J. Scherer, and M. Bean. Mediators of inflammation in leukocyte lysosomes. II. Mechanisms of action of lysosomal cationic protein upon vascular permeability in the rat. J. Exptl. Med. 122: 841–851, 1965.
Johnson, A.R., and N.C. Moran. The selective release of histamine from rat mast cells by compound 48/80 and antigen. Am. J. Physiol. 216: 453–459, 1969.
Johnson, A.R., and N.C. Moran. Inhibition of the release of histamine from rat mast cells: The effect of cold and adrenergic drugs on release of histamine by compound 48/80 and antigen. J. Pharmacol. Exptl. Therap. 175: 632–640, 1970.
Katayama, Y., J.V. Auditore, and N. Ende. Purification and characterization of a mouse mast cell esteroprotease. Exptl. Mol. Pathol. 14: 228–242, 1971.
Lagunoff, D. Structural aspects of histamine binding: The mast cell granule. In: Mechanisms of Release of Biogenic Amines, edited by U.S. Von Euler, S. Rosell, and B. Uvnas. New York: Pergammon Press, 1966, pp. 79–94.
Lagunoff, D. The properties of mast cell proteases. Biochem. Pharmacol. (Suppl.) 17: 221–227, 1968.
Levy, D.A., and J.A. Carlton. Influence of temperature on the inhibition by colchicine of allergic histamine release. Proc. Soc. Exptl. Biol. Med. 130: 1333–1336, 1969.
Lichtenstein, L.M., and S. Margolis. Histamine release in vitro: Inhibition by catecholamines and methylxanthines. Science 161: 902–904, 1968.
Lichtenstein, L.M., and A.G. Osier. Studies on the mechanisms of hypersensitivity phenomena. IX. Histamine release from human leukocytes by ragweed pollen antigen. J. Exptl. Med. 120: 507–530, 1964.
Mongar, J. L., and H.O. Schild. Cellular mechanisms in anaphylaxis. Physiol. Rev. 42: 226–270, 1962.
Moran, N.C., B. Uvnas, and B. Westerholmu Release of 5-hydroxytryptamine and histamine from rat mast cells. Acta physiol. scand. 56: 26–41, 1962.
Mota, I. The mechanism of anaphylaxis. I. Production and biological properties of “mast cell sensitizing” antibody. Immunology 7: 681–699, 1964.
Mota, I., and W. Dias da Silva. Antigen-induced damage to isolated sensitized mast cells. Nature (London) 186: 245–246, 1960.
Mota, I., and T. Ishii. Inhibition of mast cell disruption and histamine release in rat anaphylaxis in vitro: Comparison with compound 48/80. Brit. J. Pharmacol. 15: 82–87, 1960.
Orange, R.P., and K.F. Austen. Slow-reacting substances of anaphylaxis. Advan. Immunol. 10: 106–145, 1969.
Orange, R.P., D.J. Stechschulte, and K.F. Austen. Immunochemical and biologic properties of rat IgE. II. Capacity to mediate the immunologic release of histamine and slow- reacting substance of anaphylaxis (SRS-A). J. Immunol. 105: 1087–1095, 1970.
Orange, R.P., G.W. Austen, and K.F. Austen. Immunological release of histamine and slow-reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3′5′-adenosine monphosphate. J. Exptl. Med. 134: 136s–148s, 1971.
Paton, W.D.M. Compound 48/80: A potent histamine liberator Brit. J. Pharmacol. 6: 499–508, 1951.
Patterson, R., and Sparks, D.B. The passive transfer to normal dogs of skin reactivity, asthma and anaphylaxis from a dog with spontaneous ragweed pollen hypersensitivity. J. Immunol. 88: 262–268, 1962.
Perera, B.A.V., and J.L. Mongar. The role in anaphylaxis of a chymotrypsin-like enzyme in rat mast cells. Immunology 6: 478–483, 1963.
Ranadive, N.S., and C.G. Cochrane, Mechanisms of histamine release from mast cells by cationic protein (band 2) from neutrophil lysosomes. J. Immunol. 106: 506–516, 1971.
Riley, J.F. The Mast Cells. Edinburgh and London: E. & S. Livingstone, 1959.
Rothschild, A.M. Histamine release by basic compounds. In: Handbook of Experimental Pharmacology, edited by O. Eichler and A. Farar, vol. 18; Histamine and Antihistamines3 edited by M. Rocha e Silva, New York: Springer-Verlag, 1966, Part 1, pp. 386–430.
Scroggie, A.E., and L.B. Jaques. The release of histamine and heparin by antigen from the isolated perfused liver of the sensitized dog. J. Immunol. 62: 103–116, 1949.
Slorach, S.A., and B. Uvnas. Dissociation of histamine release and Na uptake in rat mast cells exposed to compound 48/80 in vitro. Acta physiol. scand. 76: 201–212, 1969.
Tasaka, K., K. Sugiyama, S. Komoto, and H. Yamasaki. Dissociation of degranulation and depolarization of the rat mesentery mast cell exposed to compound 48/80 and ATP. Proc. Japan Acad. 46: 826–830, 1970.
Thon, I.L., and B. Uvnas. Degranulation and histamine release: Two consecutive steps in the response of rat mast cells to compound 48/80. Acta physiol. scand. 71: 303–315, 1967.
Uvnäs, B. Release processes in mast cells and their activation by injury. Ann. N.Y. Acad. Sci. 116: 880–890, 1964.
Uvnäs, B., and J. Antonsson. Triggering action of phosphotidase A and chymotrypsins on degranulation of rat mesentery mast cells. Biochem. Pharmacol. 12: 867–873, 1963.
Uvnäs, B., and I.L. Thon. Evidence for enzymatic histamine release from isolated rat mast cells. Exptl. Cell Res. 23: 45–57, 1961.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1972 Plenum Press, New York
About this chapter
Cite this chapter
Johnson, A.R. (1972). Liberation of Vasoactive Materials from Mast Cells in Anaphylactic Shock. In: Hinshaw, L.B., Cox, B.G. (eds) The Fundamental Mechanisms of Shock. Advances in Experimental Medicine and Biology, vol 23. Springer, Boston, MA. https://doi.org/10.1007/978-1-4615-9014-9_34
Download citation
DOI: https://doi.org/10.1007/978-1-4615-9014-9_34
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4615-9016-3
Online ISBN: 978-1-4615-9014-9
eBook Packages: Springer Book Archive